Novo Nordisk
NVO,
shares jumped 3% as the Danish drugmaker said it ended a trial early due to efficacy of its diabetes drug Ozempic against kidney disease.
Stock decliners:
Shares of Silk Road Medical Inc.
SILK,
dropped 39% after the medical device company’s forecast fell short of Wall Street estimates, and announced its CEO was retiring.
Shares in Fresenius Medical Care
FMS,
dropped 19% and DaVita
DVA,
stock fell 18% on concerns over future dialysis sales in the wake of the Novo Nordisk trial.
Read the full article here